Bladder Cancer Manager is a symptom-tracking and clinical data-sharing tool for patients on iOS and Android.
The App DNA
What makes this app unique?
The app removes the friction of manual symptom reporting during clinical visits by providing a digital, shareable record of daily health trends.
For Patients living with bladder cancer who require tools to track symptoms, manage medications, and share health data with their clinical care teams.
What does it look like?
Key features
Syncs heart rate data from Apple Watch and other wearables for physician review.
Tracks daily pain, mood, and medication adherence via visual pie charts.
Shares journaled health data directly with care providers for remote monitoring.
How much does it cost?
The app is free, serving as a patient-facing distribution channel for the developer's B2B clinical education platform.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app is currently in a maintenance phase, with only two releases identified in the recent window. The latest release occurred 46 days ago, and the overall cadence averages to approximately one update every 2-3 months. Development is focused primarily on technical stability, layout adjustments, and resolving functional issues with core tools like calendars and symptom trackers. There is no evidence of a shift toward live operations or frequent feature expansion.
Who built it?
@Point of Care
13+ apps tracked · Medical
Osteoporosis Manager
Rheumatologic Diseases
Diabetes Health Manager
NMOSD Manager
Pulmonology and Allergy
IPF Manager
Non-Small Cell Lung Cancer
MD Keyboard
Psychiatric Disorders
Ophthalmology @Point of Care
RA Manager
Skin Cancer ManagerUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Bladder Cancer Manager
How's the Medical market?
Bladder Cancer Manager occupies a niche in the medical category, functioning as a patient-facing extension of the @Point of Care clinical suite. The lack of a subscription model signals that the developer prioritizes clinical data flow and provider-side adoption over direct consumer monetization.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Bladder Cancer Manager
Where is it heading?
The market for condition-specific management tools is consolidating around platforms that offer direct clinical integration. Bladder Cancer Manager is well-positioned as a specialized node within the @Point of Care suite, ensuring its relevance as long as the parent platform maintains its professional adoption.
- The maintenance-only release cadence indicates the app is functioning as a stable utility for the @Point of Care platform.
The SWOT
- Clinical data bridge to @Point of Care suite
- Visual symptom journaling for medical consultations
- Gamified rewards sustain daily logging habits
- Localized clinical education modules for international markets
Next best moves
Ship automated PDF report exports because patients need offline records for non-connected providers → increase utility for non-integrated care teams.
The counter-intuitive read
The app's maintenance-mode status is a strategic choice, not a failure…
Read the full takeBottom line
Bladder Cancer Manager maintains its position by serving as a specialized data-collection node for the @Point of Care professional suite, and its long-term viability rests on the depth of this clinical integration rather than standalone feature expansion.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Developer website, source
Report last updated